Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer (vol 22, pg 2582, 2011)

Y. Wu,M. M. Amonkar, B. H. Sherrill, J. O'Shaughnessy,C. Ellis,J. Baselga, K. L. Blackwell, H. J. Burstein

Annals of Oncology(2019)

引用 38|浏览27
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要